Study Conduct

ACRP and IISRA to merge

Friday, March 29, 2013 03:39 PM

The Association of Clinical Research Professionals (ACRP) and the Investigator Initiated Sponsored Research Association (IISRA) have merged.

More... »

NextDocs, Microsoft mobilize clinical trials with Trial Exchange and Windows 8

Monday, March 25, 2013 11:32 AM

NextDocs, a provider of compliance solutions for the life sciences industry, has launched its new Trial Exchange solution which provides an easy-to-use interface for investigators and site staff to access and contribute essential documents for clinical trials. 

More... »

Benitec selects Duke Clinical Research Unit as a site for HCV phase I/II trial

Monday, March 25, 2013 11:03 AM

RNAi-based therapeutics company Benitec Biopharma has selected the Duke Clinical Research Unit, the early phase unit of the Duke Clinical Research Institute (DCRI) of Durham, N.C., as a site for its upcoming phase I/II first-in-man trial for TT-034 in hepatitis C (HCV). TT-034 is being developed as a potential "one-shot-cure" for HCV.

More... »

Icon launches new Icon Signature Series to share expertise in clinical development

Friday, March 22, 2013 03:04 PM

Icon,a global provider of outsourced development services, has launched the Icon Signature Series, a new thought leadership program that offers expert insight into value-driven strategies for clinical development. 

More... »

Almac to host clinical trial workshop series

Wednesday, March 20, 2013 11:06 AM

The Almac Group is hosting its third international series of complimentary workshops this spring, titled “Protocol to Patient: Managing Clinical Supplies in an Evolving Marketplace.”

More... »

PSI, Synta Pharmaceuticals collaborate on trial

Tuesday, March 5, 2013 04:00 PM

Switzerland-based CRO PSI said it has been selected by Synta Pharmaceuticals to conduct its GALAXY-2 trial, a randomized, phase III study of Ganetespib in combination with Docetaxel versus Docetaxel alone in patients with advanced non-small cell lung cancer.  PSI currently is initiating this 500-patient study across 15-plus countries.

More... »

Xceleron, Kinetigen partner to simplify phase I investigations

Tuesday, February 26, 2013 09:06 AM

Xceleron, a provider of bioanalytical AMS services for accelerated early drug development, has formed a partnership with Kinetigen, a clinical pharmacology consulting firm specializing in pharmacokinetics. The partnership will offer drug developers simpler and more robust early clinical investigations.

More... »

ELC Group launches clinical trials services

Friday, February 22, 2013 10:19 AM

ELC Group, a provider of regulatory affairs consulting services, has launched a new clinical trials service for pharmaceutical customers worldwide.

More... »

CTTI forms patient leadership council to drive improvements in clinical trials

Friday, February 15, 2013 10:50 AM

 As part of an effort to improve the way clinical trials are conducted, the Clinical Trials Transformation Initiative (CTTI), a public-private partnership to identify practices to increase the quality and efficiency of clinical trials, has formed a 16-member council to engage patient advocates in its mission.

More... »

Genetically engineered virus extends lives of terminally-ill liver cancer patients

Wednesday, February 13, 2013 03:01 PM

A genetically-engineered virus has prolonged the lives of terminally ill liver cancer patients in a small clinical trial, according to the findings published in Nature Medicine. The results will need confirming in larger studies, but Cancer Research U.K. welcomed the advance as "an exciting step forward."

More... »